Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Singular Health Group Ltd ( (AU:SHG) ) is now available.
Singular Health Group Ltd announced the issuance of 900,000 fully paid ordinary shares following the exercise of unlisted options, raising $135,000. This move reflects the company’s ongoing efforts to strengthen its financial position and support its mission of advancing medical technology solutions. The announcement, authorized by the Board of Directors, indicates compliance with relevant provisions of the Corporations Act, ensuring transparency and adherence to regulatory standards.
The most recent analyst rating on (AU:SHG) stock is a Sell with a A$0.50 price target. To see the full list of analyst forecasts on Singular Health Group Ltd stock, see the AU:SHG Stock Forecast page.
More about Singular Health Group Ltd
Singular Health Group Ltd is a Western Australian, ASX-listed medical technology company focused on creating a seamless and integrated healthcare ecosystem. The company aims to unlock the full value of medical imaging records to enable universal access and promote interoperability, thereby maximizing patient outcomes. Its 3Dicom software solutions are designed to empower patients and practitioners by enhancing the visualization, communication, and understanding of medical imaging data, with 3Dicom MD cleared for diagnostic use in the United States.
Average Trading Volume: 593,742
Technical Sentiment Signal: Buy
Current Market Cap: A$81.4M
Learn more about SHG stock on TipRanks’ Stock Analysis page.